Infliximab,adalimumab,certolizumab
Janssen,Abbvie,UCB Pharmaceuticals
['gevokizumab', 'adalimumab', 'anakinra', 'thio', 'apremilast', 'colchicine', 'cyclophosphamide', 'certolizumab', 'canakinumab']
state-of-the-art treatment of behcet s disease and new paradigm shifts an growing place for tnfi (inflixab, adalimumab and some experience with certolizumab in uveitis) pr. gulen hatemi
#eular2023 nz 
Annals of the Rheumatic Diseases (#1 research journal in Rheumatology) & RMD Open are the official @EULAR_ORG journals. High quality, peer reviewed research.